MoldCo

MoldCo is a healthcare technology company based in Cambridge, MA, focused on helping individuals reclaim their health after mold exposure. Founded in 2023, MoldCo offers clinical-grade testing, telehealth treatment, and personalized care protocols for those suffering from mold-related illnesses, such as chronic inflammatory response syndrome. Their approach combines advanced lab diagnostics, expert-led virtual care, and research-backed treatment plans, including a patented peptide protocol for detox and repair. MoldCo’s services are designed to be accessible, affordable, and scalable, with lab tests starting at $99 and care beginning at $129, all without the need for insurance.

Potential employees may appreciate MoldCo’s mission-driven culture and rapid growth. The company is tackling a significant public health blind spot, aiming to set a new standard of care for mold toxicity and chronic inflammation. MoldCo’s team includes top clinical experts and operates with a strong emphasis on evidence-based protocols, patient-centered design, and nationwide accessibility. Employees have the opportunity to work on challenging problems with real-world impact, collaborate with visionary leaders, and contribute to a movement that is already gaining national attention and investment, including an $8M seed round to fuel further expansion.